Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease

doi:10.3748/wjg.v31.i28.105089

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1942)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

1589

Figures (1-2)

Tables (1-2)

166

Sum=1870

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=31

Jul 28, 2025 (publication date) through Aug 12, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jul 28, 2025; 31(28): 105089
Published online Jul 28, 2025. doi: 10.3748/wjg.v31.i28.105089

Full Size Figure Download Figure

Figure 1 Applications of fecal microbiota transplantation in infectious and noninfectious diseases. Besides recurrent Clostridium difficile infection, the applications of fecal microbiota transplantation have been extended to noninfectious diseases, including neuropsychiatric diseases, metabolic diseases, digestive diseases, autoimmune diseases, and other diseases such as melanoma, epithelial tumors, graft-versus-host disease, and polycystic ovary syndrome. HIV: Human immunodeficiency virus; rCDI: Recurrent Clostridium difficile infection. Created with BioRender (Supplementary material).

Citation: Ma L, Zhang MH, Xu YF, Hao YX, Niu XX, Li Y, Xing HC. Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease. World J Gastroenterol 2025; 31(28): 105089
URL: https://www.wjgnet.com/1007-9327/full/v31/i28/105089.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i28.105089